Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement

ConditionDiabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Sud Francilien

About this trial

Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and/or institutionalized patients?

Eligibility criteria

Qualifiers

Older than 18 years patient with type 1 or 2 diabetes

Treated with multiple insulin injections

Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before

Dependent on a health professional for treatment management.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Counseling home caregivers

Treatment groups

No treatment groups listed